Repurposing DrugBank compounds as NAD-dependent deacetylase sirtuin 2 inhibitors via QSAR modelling with gradient boosting algorithms and all-atom molecular simulations Mar 12, 2026· Yassir Boulaamane , Asmae Saih , Abdelkrim Guendouzi , Amal Maurady · 0 min read Last updated on Mar 12, 2026 Anti-cancer and dual inhibitory potential of PI3K/AKT and Ras/MAPK/ERK signalling of a novel zinc (II) trinuclear complex with tetradentate schiff base ligand and azido ion in prostate adenocarcinoma: synthesis, in silico and in vitro evaluation Feb 14, 2026 →